Similares a Higher Steroid Doses May Shorten AE-SARD-ILD Hospitalizations | ATS 2026

20 vecinos (text_768) · 73 views · HCPLive · Estados Unidos


★	Higher Steroid Doses May Shorten AE-SARD-ILD Hospitalizations \| ATS 2026	HCPLive @hcplivenews	73	Estados Unidos
11	Si tengo asma, ¿puedo tomar antiinflamatorios?	Alergias MedicinaTV @alergias_medicinatelevision	2.9K	España	84
5	Mepolizumab Add-On Reduces COPD Exacerbations in Triple-Therapy Patients \| ATS 2026	HCPLive @hcplivenews	1.2K	Estados Unidos	84
6	Potential Biomarker to Identify Pregnant Women at Greater Risk for #Asthma Exacerbations I ATS 2026	HCPLive @hcplivenews	453	Estados Unidos	84
16	Patient Perspectives on a Potential New Dermatomyositis Therapy: Insights from Phase 3 VALOR Trial	The Myositis Association (TMA) @myositisassociation	371	Estados Unidos	83
9	Living with Myositis: Real Talk about Steroids, Side Effects, and Support	The Myositis Association (TMA) @myositisassociation	287	Estados Unidos	84
3	Treatment of systemic sclerosis-associated interstitial lung disease: where do we stand in 2025?	ERN ReCONNET @ernreconnet	285	—	85
14	Ask the Expert Pulmonology Edition featuring Robert Hallowell, MD	The Myositis Association (TMA) @myositisassociation	241	Estados Unidos	83
13	Exercise in adult idiopathic inflammatory myopathies (IIMs)	ERN ReCONNET @ernreconnet	188	—	84
8	Lung Story Short: Interstitial Lung Disease (ILD) 101	National Jewish Health @nationaljewishhealth	174	Estados Unidos	84
17	Tezepelumab Reduced Severe Asthma Exacerbations Across Phenotypes \| ATS 2026	HCPLive @hcplivenews	122	Estados Unidos	83
20	AUTOIMMUNE EXPERT Explains why Medication WORSENS Autoimmune Disease (Do this instead!)	Lauren Geertsen @laurengeertsen	117	—	83
1	Mepolizumab Reduced COPD Hospitalizations in Eosinophilic Disease \| ATS 2026 With Gerard Criner, MD	HCPLive @hcplivenews	113	Estados Unidos	86
18	AERIFY: Phase 3 Data Reveal Challenges, Potential of Itepekimab in COPD	HCPLive @hcplivenews	105	Estados Unidos	83
12	Osteoporosis in rare and complex connective tissue diseases	ERN ReCONNET @ernreconnet	96	—	84
19	SUNRISE: Tezepelumab Shows Meaningful OCS Reduction in Severe Asthma	HCPLive @hcplivenews	78	Estados Unidos	83
15	Dupilumab Doubled Asthma Remission Odds in Type 2 Asthma:	HCPLive @hcplivenews	71	Estados Unidos	83
4	ATS 2026 Asthma Updates: Tezepelumab, Dupilumab, OCS Reduction & More \| HCPLive Expert Interviews	HCPLive @hcplivenews	70	Estados Unidos	85
2	SGLT2 Inhibitors May Reduce COPD Readmissions I ATS 2026	HCPLive @hcplivenews	48	Estados Unidos	86
10	Pegtarazimod Cuts Oxygen Need in Hospitalized COPD Patients \| ATS 2026 \| Gerald Criner, MD	HCPLive @hcplivenews	29	Estados Unidos	84
7	Does Insulin Resistance Harm the Lungs? CT Data Offers New Clues \| ATS 2026	HCPLive @hcplivenews	25	Estados Unidos	84